SOLUBLE CD163 IS A BIOMARKER FOR CARDIOVASCULAR EVENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
David, C. [1 ]
Costedoat-Chalumeau, N. [2 ]
Belhadi, D. [3 ]
Leguern, V. [2 ]
Laouenan, C. [3 ]
Boutten, A. [4 ]
Chezel, J. [1 ]
Morel, N. [2 ]
Mathian, A. [5 ]
Amoura, Z. [5 ]
Papo, T. [1 ]
Sacre, K. [1 ]
机构：
[1] Univ Paris Bichat, Med Interne, Paris, France
[2] Univ Paris Cochin, Med Interne, Paris, France
[3] Univ Paris Bichat, URC, Paris, France
[4] Univ Paris Bichat, Biochim, Paris, France
[5] Sorbonne Univ Pitie, Med Interne, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.19
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0450
引用
收藏
页码：1353 / 1353
页数：1
相关论文
共 50 条
  • [31] Increased levels of soluble CD163 in periodontitis patients
    Detzen, Laurent
    Chen, Steven C. Y.
    Cheng, Bin
    Papapanou, Panos N.
    Lalla, Evanthia
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2017, 44 (06) : 585 - 590
  • [32] THE LEVELS OF SOLUBLE CD163 IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Tosovsky, M.
    Bradna, P.
    Andrys, C.
    Andrysova, K.
    Cermakova, E.
    Soukup, T.
    Kubinova, K.
    Krejsek, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 857 - 858
  • [33] Urine soluble CD163 is a promising biomarker for the diagnosis and evaluation of lupus nephritis (vol 13, 935700, 2022)
    Huang, Yun-Ju
    Lin, Chiung-Hung
    Yang, Huang-Yu
    Luo, Shue-Fen
    Kuo, Chang-Fu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Correlation of Urinary Soluble CD163 Levels with Clinicopathological Features in Lupus Nephritis: Its Role as a Potential Biomarker
    Venkataraman, Shilpa
    Singh, Ankita
    Murari, Manjula
    Agrawal, Vinita
    Aggarwal, Amita
    Pandey, Rakesh
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma
    Kasper Munch Lauridsen
    Marianne Hokland
    Sinan Al-Karradi
    Holger Jon Møller
    Frede Donskov
    Morten Nørgaard Andersen
    Cancer Immunology, Immunotherapy, 2023, 72 : 461 - 473
  • [36] Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma
    Lauridsen, Kasper Munch
    Hokland, Marianne
    Al-Karradi, Sinan
    Moller, Holger Jon
    Donskov, Frede
    Andersen, Morten Norgaard
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 461 - 473
  • [37] Biological variation of soluble CD163
    Moller, HJ
    Petersen, PH
    Rejnmark, L
    Moestrup, SK
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2003, 63 (01): : 15 - 21
  • [38] Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis
    Hassan, Waleed Ahmed Salah Eldeen
    Baraka, Eman Abd Elaleem
    Elnady, Basant Mohammed
    Gouda, Tahany Mahmoud
    Fouad, Nehad
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2016, 3 (03) : 95 - 100
  • [39] Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries
    Piatkowski, Andrzej
    Grieb, Gerrit
    Das, Rittuparna
    Bozkurt, Ahmet
    Ulrich, Dietmar
    Pallua, Norbert
    INDIAN JOURNAL OF PLASTIC SURGERY, 2011, 44 (01) : 118 - 123
  • [40] Utility of urinary soluble CD163 as a novel biomarker for the detection of IgA nephropathy
    Chia, Chelsea
    Chan, Gek Cher
    Teo, Boon Wee
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2037 - I2038
12345